AB
XENT

Amalgamated Bank’s Intersect ENT, Inc XENT Stock Holding History

Amalgamated Bank’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,422
Closed -$152K – 3332
2022
Q1 		$152K Buy
+5,422
New +$149K ﹤0.01% 2046

Amalgamated Bank's XENT Position: Q2 2022 in Review

Amalgamated Bank sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 5,422 shares — an estimated $152K sold.

Amalgamated Bank first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $152K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Amalgamated Bank reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 5,422 Intersect ENT, Inc shares in Q2 2022, an estimated $152K.
  • Amalgamated Bank first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Intersect ENT, Inc position peaked at $152K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.